Catherine Ellis

7PUBLICATIONS
80CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 21, 2026
Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.

Francesca Palandri, Venediktos Kapetanakis, Balázs Dobi

|Dec 22, 2025
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Danny Rischin, Aaron R Hansen, Ezra E W Cohen

|Dec 17, 2024
Anemia in Myelofibrosis: A Focus on Proactive Management and the Role of Momelotinib.

Haifa Kathrin Al-Ali, Andrew T Kuykendall, Catherine E Ellis

|Aug 27, 2024
Momelotinib: Mechanism of action, clinical, and translational science.

Georgios Vlasakakis, Michael T McCabe, Yu Liu Ho

|Feb 06, 2024
Anemia-related response end points in myelofibrosis clinical trials: current trends and need for renewed consensus.

Barbara J Klencke, Rafe Donahue, Boris Gorsh

|Aug 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade.

Sapna Yadavilli, Jeremy D Waight, Sara Brett

Pageof 2

Frequent Collaborators

2 joint publications

Marc Ballas

2 joint publications

Danny Rischin

2 joint publications

Michael J Chisamore

2 joint publications

Georgios Vlasakakis